Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David Allard
Observed name:
Allard, David
Institutions:
Centre Hospitalier de l’Université de Montréal,
Institut du cancer de Montréal,
McGill University,
Université de Montréal
Observed institutions:
Centre Hospitalier de l’Université de Montréal,
Institut du cancer de Montréal,
McGill University,
Université de Montréal
ORCID:
0000-0001-8820-8161
Observed ORCID:
0000-0001-8820-8161
OpenAlex ID:
A5041459747
Works
42
Awards
2
The adenosine pathway in immuno-oncology
2020
·
Bertrand Allard
, David Allard
, et al.
·
Nature Reviews Clinical Oncology
·
666
Targeting the CD73-adenosine axis in immuno-oncology
2018
·
David Allard
, Pavel Chrobak
, et al.
·
Immunology Letters
·
175
CD73–Adenosine: A Next-Generation Target in Immuno-Oncology
2016
·
David Allard
, Bertrand Allard
, et al.
·
Immunotherapy
·
153
On the mechanism of anti-CD39 immune checkpoint therapy
2020
·
David Allard
, Bertrand Allard
, et al.
·
Journal for ImmunoTherapy of Cancer
·
141
PDF
Targeting A2 adenosine receptors in cancer
2017
·
David Allard
, Martin Turcotte
, et al.
·
Immunology and Cell Biology
·
126
PDF
CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy
2017
·
Martin Turcotte
, David Allard
, et al.
·
Cancer Research
·
118
DNA hypomethylating agents increase activation and cytolytic activity of CD8+ T cells
2021
·
Helen Loo Yau
, Emma Bell
, et al.
·
Molecular Cell
·
96
PDF
CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer
2022
·
Célia Jacoberger-Foissac
, Isabelle Cousineau
, et al.
·
Cancer Immunology Research
·
84
PDF
Targeting the adenosine pathway for cancer immunotherapy
2019
·
Akil Hammami
, David Allard
, et al.
·
Seminars in Immunology
·
84
Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis
2019
·
Bertrand Allard
, Isabelle Cousineau
, et al.
·
OncoImmunology
·
35
PDF
Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma
2023
·
Bertrand Allard
, Célia Jacoberger-Foissac
, et al.
·
Cell Reports Medicine
·
34
PDF
High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer
2021
·
Yacine Bareche
, Sandra Pommey
, et al.
·
Journal for ImmunoTherapy of Cancer
·
34
PDF
Adenosine Uptake through the Nucleoside Transporter ENT1 Suppresses Antitumor Immunity and T-cell Pyrimidine Synthesis
2024
·
David Allard
, Jeanne Cormery
, et al.
·
Cancer Research
·
33
PolyI:C and CpG Synergize with Anti-ErbB2 mAb for Treatment of Breast Tumors Resistant to Immune Checkpoint Inhibitors
2016
·
Roxanne Charlebois
, Bertrand Allard
, et al.
·
Cancer Research
·
33
The CD73 immune checkpoint promotes tumor cell metabolic fitness
2023
·
David Allard
, Isabelle Cousineau
, et al.
·
eLife
·
28
PDF
Methods to Evaluate the Antitumor Activity of Immune Checkpoint Inhibitors in Preclinical Studies
2016
·
Bertrand Allard
, David Allard
, et al.
·
Methods in molecular biology
·
13
Publisher Correction: The adenosine pathway in immuno-oncology
2020
·
Bertrand Allard
, David Allard
, et al.
·
Nature Reviews Clinical Oncology
·
11
PDF
CD73 Promotes Chronic Lymphocytic Leukemia
2022
·
David Allard
, Pavel Chrobak
, et al.
·
Cancers
·
9
PDF
CD73-A2a adenosine receptor axis promotes innate B cell antibody responses to pneumococcal polysaccharide vaccination
2018
·
David Allard
, Roxanne Charlebois
, et al.
·
PLoS ONE
·
7
PDF
The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver β-catenin in colorectal cancer
2026
·
Mariana Acevedo
, Florence Dô
, et al.
·
Oncogene
·
5
Assessing the Efficacy of Immune Checkpoint Inhibitors in Preclinical Tumor Models
2023
·
Celia Jacoberger-Foissac
, Bertrand Allard
, et al.
·
Methods in molecular biology
·
3
DNA-Demethylating Agents Enhance Cytolytic Activity of CD8 T Cells and Anti-Tumor Immunity
2018
·
Helen Loo Yau
, Ankur Chakravarthy
, et al.
·
SSRN Electronic Journal
·
2
PRMT7 restricts CD8+ T cells expansion via the NF-ΚB pathway
2026
·
Nivine Srour
, Kaixiu Luo
, et al.
·
Nature Communications
·
1
PDF
Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy
2026
·
Samya Aouad
, Maleck Kadiri
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
Data from Adenosine Uptake through the Nucleoside Transporter ENT1 Suppresses Antitumor Immunity and T-cell Pyrimidine Synthesis
2025
·
David Allard
, Jeanne Cormery
, et al.
·
1
Show more works
View as search
Works count:
42
Citation count:
1,894
H-index:
15
I10-index:
17
Year
Topic
Type